Eftyhia Vardas

Eftyhia Vardas FC Path is an honorary extra-ordinary professor in medical virology at the Department of Medical Virology, University of Stellenbosch, and head of virology at Lancet Laboratories in Johannesburg. She is a member of the COVID-19 Ministerial Advisory Committee to the South African minister of health.

Eftyhia Vardas
EducationUniversity of the Witwatersrand
Medical career
Institutions

Education

Vardas graduated from the University of the Witwatersrand (UoW) with a BSc in medical physiology and subsequently received her MBBCh, followed by DTM&H and DPH.[1][2]

Career

She undertook her specialist training at the National Institutes of Communicable diseases in South Africa and also qualified as a fellow of the South African College of Pathologists in clinical virology.[1] She gained a diploma in tropical medicine and hygiene, public health from the UoW and infectious disease modelling from the London School of Tropical Hygiene and Medicine.[2]

Vardas is a member of the COVID-19 Ministerial Advisory Committee to the South African minister of health.[1][2] She is an honorary extra-ordinary professor in medical virology at the Department of Medical Virology, University of Stellenbosch, and head of virology at Johannesburg's Lancet Laboratories,[3] where, in November 2021, observations of a new SARS-CoV-2 virus led to the discovery of Omicron.[4]

Her past research has included trials on developing therapeutic vaccines for HIV/AIDS,[5] hepatitis B vaccines and human papilloma virus vaccines.[1]

Other work

In 2009 she qualified for the diploma of Cape Wine Master with a dissertation titled "The fall and rise of Sémillon in South Africa".[6][7]

Selected publications
  • Giuliano, Anna R.; Palefsky, Joel M.; Goldstone, Stephen; Moreira, Edson D.; Penny, Mary E.; Aranda, Carlos; Vardas, Eftyhia; Moi, Harald; Jessen, Heiko; Hillman, Richard; Chang, Yen-Hwa; Ferris, Daron; Rouleau, Danielle; Bryan, Janine; Marshall, J. Brooke; Vuocolo, Scott; Barr, Eliav; Radley, David; Haupt, Richard M.; Guris, Dalya (3 February 2011). "Efficacy of Quadrivalent HPV Vaccine against HPV Infection and Disease in Males". New England Journal of Medicine. 364 (5): 401–411. doi:10.1056/NEJMoa0909537. ISSN 0028-4793. PMC 3495065. PMID 21288094. (Co-author)
  • Vardas, E.; Giuliano, A. R.; Goldstone, S.; Palefsky, J. M.; Moreira, E. D.; Penny, M. E.; Aranda, C.; Jessen, H.; Moi, H.; Ferris, D. G.; Liaw, K.-L.; Marshall, J. B.; Vuocolo, S.; Barr, E.; Haupt, R. M.; Garner, E. I. O.; Guris, D. (1 January 2011). "External Genital Human Papillomavirus Prevalence and Associated Factors Among Heterosexual Men on 5 Continents". The Journal of Infectious Diseases. 203 (1): 58–65. doi:10.1093/infdis/jiq015. ISSN 0022-1899. PMC 3086430. PMID 21148497. (Co-author)
  • Hillman, Richard J.; Giuliano, Anna R.; Palefsky, Joel M.; Goldstone, Stephen; Moreira, Edson D.; Vardas, Eftyhia; Aranda, Carlos; Jessen, Heiko; Ferris, Daron G.; Coutlee, Francois; Marshall, J. Brooke; Vuocolo, Scott; Haupt, Richard M.; Guris, Dalya; Garner, Elizabeth I. O. (7 December 2011). "Immunogenicity of the Quadrivalent Human Papillomavirus (Type 6/11/16/18) Vaccine in Males 16 to 26 Years Old". Clinical and Vaccine Immunology. 19 (2): 261–267. doi:10.1128/CVI.05208-11. PMC 3272915. PMID 22155768. (Co-author)

References
  1. "Eftyhia Vardas". The Conversation. Retrieved 3 January 2022.
  2. "Prof Eftyhia Vardas". WCIM 2018. Retrieved 3 January 2022.
  3. "Trial of potentially variant-proof vaccine ongoing in Western Cape | Institute Of Infectious Disease and Molecular Medicine". www.idm.uct.ac.za. Retrieved 3 January 2022.
  4. "Inside the South African lab that discovered Omicron". Africanews. Retrieved 7 January 2022.
  5. Abbott, Alison (27 July 2020). "Therapeutic HIV vaccines show promise". Scientific American. Retrieved 7 January 2022.
  6. "Vardas, Eftyhia (Prof) | Institute of Cape Wine Masters". www.icwm.co.za. Retrieved 7 January 2022.
  7. "Five new Cape Wine Masters graduate". wine.co.za. 13 May 2009. Retrieved 7 January 2022.
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.